BEnzyl 4-[2-(tert-butoxy)-2-oxoethyl]piperazine-1-carboxylate

Catalog No.: 
ACFBIL240
CAS No.: 
112275-51-1
Molecular Formula: 
C18H26N2O4
Molecular Weight: 
334.42
BEnzyl 4-[2-(tert-butoxy)-2-oxoethyl]piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$358.001 week1 week
250mg95%$715.001 week1 week
1g95%$1195.001 week1 week

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBEnzyl 4-[2-(tert-butoxy)-2-oxoethyl]piperazine-1-carboxylate
IUPAC Namebenzyl 4-(2-(tert-butoxy)-2-oxoethyl)piperazine-1-carboxylate
Molecular FormulaC18H26N2O4
Molecular Weight334.42
SMILESCC(C)(OC(CN1CCN(C(OCC2=CC=CC=C2)=O)CC1)=O)C
InChI KeyNXTOTSQOMBNWFA-UHFFFAOYSA-N
Synonymbenzyl 4-(2-tert-butoxy-2-oxoethyl)piperazine-1-carboxylate;NXTOTSQOMBNWFA-UHFFFAOYSA-N;1-Piperazineacetic acid, 4-[(phenylmethoxy)carbonyl]-, 1,1-dimethylethyl ester
CAS No.112275-51-1

Synthetic Route by SureRoute

1. ACFBIL240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJLZB581 route compound structure diagram
    ACJLZB58131166-44-6In Stock
  4. Then
  5. ACFBIL240 route product structure diagram
    ACFBIL240112275-51-1
Inquiry

2. ACFBIL240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJLZB581 route compound structure diagram
    ACJLZB58131166-44-6In Stock
  4. Then
  5. ACFBIL240 route product structure diagram
    ACFBIL240112275-51-1
Inquiry

3. ACFBIL240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPDIE017 route compound structure diagram
    ACPDIE017112257-22-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFBIL240 route product structure diagram
    ACFBIL240112275-51-1
Inquiry

Comments (0)